Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
01672
01672
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
01672 News
S Korean Investors' Top HK Stock Purchase This Year: MINIMAX, Totaling USD 20.7M
3d ago
aastocks
ASCLETIS-B Unveils 4% Discounted Share Placement Aiming to Raise HKD835 Million
Feb 03 2026
aastocks
HSI Closes Down 331 Points Amid Weakness in Chip and Chinese Developer Stocks; Chinese Biotechs Show Steady Gains
Dec 09 2025
aastocks
Citi Research: Phase 2a Results of ASCLETIS-B's ASC30 Highlight Best-in-Class Potential and Enhanced Tolerability
Dec 09 2025
aastocks
ASCLETIS-B Rises 22% Following Positive Results of GLP-1 Drug ASC30 in Obesity Treatment Trial
Dec 09 2025
aastocks
G Sachs Provides ST Risk Assessment for Three Firm Types as US Expected to Increase Scrutiny on CN Innovative Drugs, Potentially Creating 'Headline Risks' for CN Pharmaceutical Companies
Sep 11 2025
aastocks
HSI Rises 48 Points at Midday; SINO BIOPHARM Drops Over 6%; EAST BUY Increases by 10%
Aug 19 2025
aastocks
ASCLETIS-B Declines Approximately 10% at Opening After Securing $470M Through 9.9% Discounted Share Placement
Aug 19 2025
aastocks
ASCLETIS-B Seeks to Generate HKD468M Net Through Top-up Placing at 9.9% Discount; Controlling Shareholders to Receive HKD388M
Aug 19 2025
aastocks
Show More News
